• KARM
  • Contact us
  • E-Submission
ABOUT
ARTICLE TYPES
BROWSE ARTICLES
AUTHOR INFORMATION

Articles

Original Article

Immediate Effects of Manual Muscle Stretching on Respiratory Capacity, Heart Rate Variability, and Diaphragmatic Function in Patients With COPD

Annals of Rehabilitation Medicine 2026;50(4):265-277.
Published online: August 31, 2026

1Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan City, Taiwan

2Department of Physical Therapy, College of Medicine, Tzu Chi University, Hualien, Taiwan

3Department of Physical Therapy, College of Medicine, National Cheng Kung University, Tainan City, Taiwan

4Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan City, Taiwan

5Division of Critical Care Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan City, Taiwan

6Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan City, Taiwan

Correspondence: Chin-Wei Kuo Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, No.1, University Road, Tainan City 701, Taiwan. Tel: +886-6-2353535 Fax: +886-6-2359033 E-mail: kbh557@gmail.com
Kun-Ling Tsai Department of Physical Therapy, College of Medicine, National Cheng Kung University, No.1, University Road, Tainan City 701, Taiwan. Tel: +886-6-2353535 Fax: +886-6-2370411 E-mail: kunlingtsai@mail.ncku.edu.tw
• Received: February 12, 2026   • Revised: March 21, 2026   • Accepted: May 21, 2026

© 2026 by Korean Academy of Rehabilitation Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 1,340 Views
  • 38 Download
prev next
  • Objective
    To investigate the acute physiological responses following a single session of manual muscle stretching in patients with moderate to severe chronic obstructive pulmonary disease (COPD).
  • Methods
    A single-group pre–post design was used. Nineteen participants with moderate to severe COPD received one session of manual stretching, incorporating passive stretching and muscle energy techniques targeting the anterior scalene, upper trapezius, pectoralis, and diaphragm muscles. Primary outcomes included spirometry values, static lung volumes, heart rate variability (HRV), and diaphragmatic ultrasound. Secondary outcomes included respiratory muscle strength, upper limb flexibility, and symptom scores.
  • Results
    Following the intervention, participants exhibited a significant increase in expiratory reserve volume and diaphragmatic mobility, accompanied by a decrease in resting heart rate. HRV parameters (SDNN, RMSSD, LF, HF, and TP) showed significant changes following the intervention. Maximal inspiratory pressure increased from 76±47% to 85±51%, and maximal expiratory pressure increased from 55±30% to 67±34%, along with enhanced upper limb flexibility. Chest tightness, as assessed by the COPD Assessment Test, was significantly reduced. However, no significant changes were observed in spirometry values (FEV1, FVC, FEV1/FVC), other static lung volumes (TV, IRV, IC, VC), standardized HRV indices (HFnu, LFnu, LF/HF), or modified Medical Research Council scores.
  • Conclusion
    A single session of manual muscle stretching may be associated with immediate changes in respiratory mechanics, autonomic function, and symptom perception in patients with COPD.
Chronic obstructive pulmonary disease (COPD) is a common condition associated with significant symptom burden and functional limitation. According to Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines, management focuses on symptom relief and reduction of exacerbation risk [1]. Dyspnea is a key symptom in COPD and is often associated with increased work of breathing [2]. It is also associated with altered breathing patterns and increased reliance on upper chest wall activity [3]. Airway narrowing in COPD contributes to expiratory flow limitation and may lead to increased reliance on accessory respiratory muscles [4]. COPD is also characterized by lung hyperinflation, which contributes to air trapping and increased symptom burden [5]. Lung hyperinflation may impair diaphragmatic function by altering its mechanical position and reducing its efficiency [6]. Reduced diaphragmatic mobility has been associated with decreased exercise capacity and increased dyspnea in patients with COPD [7]. In addition, changes in lung volumes, such as increased residual volume (RV) and total lung capacity (TLC), further reflect impaired respiratory mechanics [8].
COPD is associated with altered cardiac autonomic function, typically characterized by increased sympathetic activity and reduced parasympathetic modulation [9]. Heart rate variability (HRV) is commonly used to assess autonomic function, and reduced HRV has been linked to increased cardiovascular risk and exacerbation in COPD [10]. These findings suggest a close relationship between respiratory dysfunction and autonomic regulation [11]. Respiratory muscle weakness further impairs HRV, particularly during respiratory maneuvers, thereby altering cardiovascular responses during breathing cycles. These findings highlight the critical interplay between respiratory function and cardiac autonomic control in the management of COPD.
Previous studies have suggested that manual therapy interventions, including stretching and soft tissue techniques, may improve respiratory function and alleviate dyspnea in patients with COPD [12]. These interventions may also be associated with changes in autonomic regulation [13]. Some studies have reported improvements in lung volumes and respiratory parameters following manual therapy interventions [14]. However, other studies suggest that although such approaches are feasible, their effects on lung function and exercise capacity remain inconsistent [15]. Emerging evidence suggests that diaphragmatic release may acutely influence autonomic activity. A pilot study reported immediate changes in heart rate and HRV following diaphragmatic intervention in patients with COPD [16]. Muscle stretching has been associated with reduced muscle stiffness and improved mobility, which may contribute to improved respiratory function and exercise tolerance [13,17]. Studies focusing on diaphragmatic stretching in COPD patients have also reported improvements in diaphragmatic mobility and functional outcomes [16].
However, despite these advances, few studies have specifically examined the effects of manual stretching of accessory respiratory muscles in patients with COPD. Stretching of accessory respiratory muscles, including the diaphragm and upper chest wall muscles, may be associated with reduced muscle activity and improved chest wall mobility [18]. To date, evidence concerning how accessory respiratory muscle stretching affects lung function, HRV, and diaphragmatic performance in patients with COPD is limited. Therefore, this study aimed to explore the immediate physiological responses of key respiratory muscles to manual stretching in patients with moderate to severe COPD.
Research design
A single-group pre- and post-intervention design was used in this prospective cohort study. The study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. Key STROBE items were applied to ensure transparency in study design, participant selection, variables, statistical analyses, and reporting. Further details are provided in the Supplementary Material S1. This study was approved by the Institutional Review Board at National Cheng Kung University Hospital (NCKUH) (Registration Number: B-ER-111-470) and is registered on ClinicalTrials.gov with the identifier NCT06389734. A schematic overview of the study protocol and outcome measures is shown in Fig. 1. The research was conducted from February 2023 to March 2024. We enrolled patients with moderate to severe COPD from the Department of General Internal Medicine and the Department of Thoracic Medicine at National Cheng Kung University Hospital. Inclusion criteria were: (1) clinically diagnosed COPD with GOLD grades II–IV; (2) no acute exacerbation within the past two months; (3) ability to follow instructions; and (4) stable clinical condition. All participants were clinically diagnosed with COPD by board-certified pulmonologists in the outpatient clinic. GOLD staging (grades II–IV) was determined using historical post-bronchodilator spirometry obtained from electronic medical records, in accordance with GOLD criteria (post-bronchodilator forced expiratory volume in one second/forced vital capacity [FEV1/FVC]<0.70 and FEV1% predicted thresholds). These historical spirometric values were used exclusively for diagnostic confirmation and eligibility. In contrast, spirometry parameters reported in this study represent single-day measurements collected during the study visit and were not used for COPD diagnosis or GOLD classification. Exclusion criteria included acute heart failure or arrhythmia, pulmonary hypertension, neuromuscular or skeletal disorders, prior chest surgery, uncontrolled medical conditions (e.g., diabetes, hypertension, hyperthyroidism), rheumatic diseases, and dependence on oxygen supplementation. Eligible participants provided informed consent prior to enrollment, and medical history was recorded before the study.
Each participant underwent a single treatment session consisting of a preintervention assessment, manual muscle stretching, and a postintervention assessment. All interventions were administered by a licensed physical therapist with more than three years of clinical experience. Participants received a single session of manual muscle stretching, including passive muscle stretching and muscle energy techniques. Passive stretching was applied to the upper trapezius and diaphragm muscles with participants in the supine position, using therapist-assisted techniques to achieve end-range elongation [19]. For diaphragmatic stretching, the therapist applied manual techniques to the lower rib cage during breathing cycles, facilitating lateral expansion during inhalation and assisted compression during exhalation [20]. Stretching intensity was determined based on muscle tension at end range and maintained for 15–30 seconds. Each stretching session consisted of three repetitions per set, totaling three sets, with a 30-second rest between sets. Muscle energy techniques were applied to the anterior scalene and pectoral muscles. Participants were positioned supine, with slight contralateral rotation and side-bending of the head for anterior scalene treatment. The therapist stabilized the sternum and applied contact to the cervical region. Participants were instructed to perform a gentle isometric contraction. The contraction was maintained for 5–7 seconds during inhalation. Upon relaxation during exhalation, the therapist applied assisted stretching in a caudal direction for approximately 30 seconds. For the pectoral muscles, participants remained supine with the therapist positioned ipsilaterally. The therapist stabilized the sternum and applied resistance to the shoulder in a posterolateral direction. Participants performed an anteriorly directed isometric contraction for 5–7 seconds. After relaxation, the therapist applied assisted stretching in the posterolateral direction for approximately 30 seconds [21]. These techniques were performed for three repetitions per set, with a total of three sets and 30-second rest intervals. The entire manual intervention included approximately 15 minutes of passive muscle stretching followed by 15 minutes of muscle energy, for a total duration of 30 minutes. To enhance procedural transparency and reproducibility, Fig. 2 provides photographic demonstrations of the manual stretching techniques applied to the anterior scalene, upper trapezius, pectoralis, and diaphragm muscles.
Measurements
This study included two time points: pretreatment (5 minutes before intervention) and posttreatment (5 minutes after intervention), to assess the immediate effects of a single session of manual muscle stretching on lung function, respiratory muscle strength, HRV, diaphragm function, and upper extremity flexibility. Symptom assessments were also conducted using standardized questionnaires.
Lung function measurements
Static lung volumes included tidal volume (TV), inspiratory reserve volume (IRV), expiratory reserve volume (ERV), inspiratory capacity (IC), and vital capacity (VC). Lung volumes were measured using a spirometer (microQuark; COSMED) with participants seated and wearing a nose clip. Participants performed maximal inhalation to TLC and exhalation to RV. Three acceptable VC maneuvers were performed, and the highest value was recorded [22]. Spirometry was performed to assess airflow limitations. Parameters included FVC, FEV1, and the FEV1/FVC ratio. Participants performed standardized spirometry maneuvers while sitting and wearing a nose clip. Testing followed American Thoracic Society/European Respiratory Society guidelines, with at least three acceptable maneuvers, and average values were used for analysis [23].
HRV measurements
HRV is a noninvasive measure of autonomic nervous system function based on variations in consecutive R–R intervals. HRV was analyzed using time-domain and frequency-domain methods. These parameters reflect autonomic regulation [24].
Time-domain indices included standard deviation of NN intervals (SDNN) and root mean square of successive differences (RMSSD), reflecting overall variability and parasympathetic activity, respectively. Frequency-domain analysis included high-frequency (HF), low-frequency (LF), and low-to-high frequency ratio (LF/HF ratio) components, representing parasympathetic activity, autonomic balance, and sympathovagal modulation [11]. HRV was recorded using a 12-lead ECG system (SE-1515; EDAN Instruments). Participants were instructed to avoid caffeine, alcohol, and excessive physical activity prior to testing. Since bronchodilators are commonly used in COPD patients, participants were asked to take their bronchodilator before the trial to maintain baseline consistency. Participants were in the supine position, and the therapist attached a chest and limb lead. HRV data were recorded for 300 seconds, and R–R intervals were analyzed to derive HRV parameters [25].
Diaphragmatic ultrasonography measurements
Diaphragmatic ultrasonography (LOGIQ e; GE Healthcare) was used to assess diaphragm excursion and thickness. For diaphragm excursion, participants were positioned supine with a 10°–15° upper body elevation. A convex probe (3–8 MHz) was placed in the subcostal region along the midclavicular or anterior axillary line. The diaphragm was identified in B-mode, and excursion was measured using M-mode. Participants performed quiet breathing followed by maximal respiratory maneuvers. For diaphragm thickness, participants were positioned supine with a 30°–45° upper body elevation. A linear probe (10–22 MHz) was placed at the zone of apposition. Thickness was measured at end-inspiration (TEI) and end-expiration (TEE) during respiratory maneuvers. The diaphragmatic thickening fraction (TF) was calculated as (TEI-TEE)/TEE×100. The average of three measurements was used for analysis.
Respiratory muscle strength measurements
Respiratory muscle strength was assessed using maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP). Measurements were performed using a respiratory pressure device (GiO™; GaleMed). Participants performed maximal voluntary inspiration and expiration to measure MIP and MEP, respectively. Three trials were performed, and the highest value was recorded.
MIP and MEP values were expressed as percentages of predicted values (% predicted), calculated using sex- and age-specific reference equations by Evans and Whitelaw, 2009 [26].
Upper extremity flexibility measurements
Upper extremity flexibility was assessed using standardized positional measurements. Pectoralis minor flexibility was evaluated by measuring the distance between anatomical landmarks and the support surface, with shorter distances indicating greater flexibility. Upper trapezius flexibility was assessed by measuring the distance between the mastoid process and acromion during contralateral lateral flexion, with greater distances indicating increased flexibility. The Apley’s scratch test was used to assess shoulder flexibility. The distance between the middle fingers was recorded, with greater distances indicating reduced flexibility.
Symptom questionnaires
Symptoms were assessed using the COPD Assessment Test (CAT) and the modified Medical Research Council (mMRC) scale. The mMRC scale reflects the severity of dyspnea-related functional limitation, with higher scores indicating greater impairment. The CAT assesses health status in COPD, with scores ranging from 0 to 40, where higher scores indicate worse health status. In accordance with the GOLD symptom classification, a CAT score of 10 and an mMRC score of 2 are used as cutoff points to categorize different groups and provide different treatment strategies [1].
Statistical analysis
The sample size (n=19) was determined based on feasibility considerations, as this study aimed to explore immediate physiological responses. This sample size is comparable to that of previous studies investigating acute respiratory interventions in COPD [14,27]. Data normality was assessed using the Shapiro–Wilk test. Paired t-tests were used for normally distributed data, and Wilcoxon signed-rank tests were applied for non-normally distributed data. Results are presented as mean±standard deviation or median (interquartile range), respectively. For variables with non-normal distributions, the Wilcoxon signed-rank test was additionally applied. Both parametric and non-parametric analyses were conducted to account for potential deviations from normality, particularly for variables with skewed distributions. The statistical significance level was set at p<0.05. All the statistical analyses were performed using SPSS software version 26 (IBM Corp.), and the figures were produced using Prism version 9.5.0 (GraphPad Software).
In this prospective cohort study, participants were recruited between February 2023 and March 2024. A total of nineteen individuals with COPD were enrolled, all of whom provided signed informed consent. All participants completed the study, and their data were included in the final analysis. The participants included twelve males and seven females, with a mean age of 64.2±9.5 years, mean height of 160.7±6.7 cm, mean weight of 58.5±10.5 kg, and mean BMI of 22.6±3.7. In accordance with the GOLD diagnostic criteria, ten participants were in Stage 2, six were in Stage 3, and three were in Stage 4. As shown in Fig. 3, 68.4% of the participants (13 out of 19) scored ≥2 on the chest tightness item of the CAT, representing mild to severe chest tightness. Among these, moderate chest tightness (score 3) was the most frequently reported category (31.6%). All the subjects underwent manual muscle stretching and completed both the pretest and posttest on the same day. The participants’ characteristics are displayed in Table 1.
Lung function and respiratory muscle strength
Lung function and respiratory muscle strength outcomes were analyzed using paired t-tests, with Wilcoxon signed-rank tests applied for variables with non-normal distributions (notably MIP and MEP percentage-predicted values). Static lung capacity before and after manual muscle stretching is presented in Fig. 4. The mean pretest values were 0.79±0.62 L (TV), 0.32±0.21 L (ERV), 1.18±0.78 L (IRV), 1.98±0.93 L (IC), and 2.31±0.91 L (VC). Specifically, ERV increased significantly (paired t-test, p<0.001), from 0.32±0.21 to 0.62±0.33 L. However, no significant changes were observed in the TV, IRV, IC, or VC (p>0.05). The mean pretest spirometry values were: FEV1 1.27±0.56 L (53.5% predicted), FVC 2.10±0.84 L (69.6% predicted), and FEV1/FVC ratio 75.5±17.4%. Specifically, no significant changes were observed in the FEV1, FVC, or the FEV1/FVC ratio (p>0.05). In terms of respiratory muscle strength, manual muscle stretching was associated with changes in absolute respiratory muscle strength, although findings varied across statistical methods. Mean MEP increased significantly from 56.80±34.95 to 68.65±36.65 cmH2O (paired t-test p<0.001; Wilcoxon signed-rank test p=0.003). Mean MIP increased from -66.01±45.85 to -72.79±48.23 cmH2O, reaching significance by paired t-test (p=0.04), but not by Wilcoxon signed-rank test (p=0.096). In contrast, when expressed as percentage predicted values, neither MEP (0.55±0.30 → 0.67±0.34; paired t-test p=0.120; Wilcoxon p=0.067) nor MIP (0.76±0.47 → 0.85±0.51; paired t-test p=0.434; Wilcoxon p=0.144) demonstrated statistically significant pre–post differences. Only absolute MEP showed consistent improvement across both parametric and non-parametric tests, whereas changes in absolute MIP were method-dependent. Table 2 summarizes the primary findings. Due to skewed distributions of MIP and MEP, Supplementary Table S1 provides both parametric and non-parametric comparisons.
HRV
HRV variables were analyzed using the Wilcoxon signed-rank test. The RHR decreased significantly (p<0.05), from 79.5 (68.2–86.5) to 69.5 (60.0–77.5) bpm, the SDNN increased significantly (p<0.05), from 20.3 (15.0–30.5) to 32.0 (21.6–38.4) ms, and the RMSSD increased significantly (p<0.05), from 14.7 (10.2–25.6) to 24.8 (14.6–37.3) ms. In the frequency-domain analysis, pretest median values were: HF 59.9 (18.4–105.9) ms2, LF 47.8 (23.9–126.2) ms2, TP 270.6 (150.8–716.3) ms2, and LF/HF ratio 1.001. Following manual muscle stretching, HF, LF, and TP increased (all p<0.05), with HF to 133.4 (62.6–182.7) ms2, LF to 117.3 (60.6–257.3) ms2, and TP to 456.4 (272.6–1,441.1) ms2. No significant change was found in the LF/HF ratio (p>0.05). Normalized values were: HF 48.1 (20.6–55.2) normalized units (n.u.), and LF 43.3 (24.0–61.7) n.u. No significant changes were observed in these normalized values (p>0.05). Changes in the time domain and frequency domain of the HRV are illustrated in Fig. 5.
Diaphragmatic ultrasonography
Diaphragmatic parameters were analyzed using paired t-tests. Mean pretest diaphragmatic parameters were: diaphragmatic excursion 51.6±16.0 mm; end-inspiratory thickness 4.53±1.19 mm; end-expiratory thickness 1.95±0.44 mm; and diaphragmatic TF 1.36±0.63. The results of the analysis revealed significant differences between the pretest and posttest measurements after manual muscle stretching was performed. Specifically, diaphragmatic excursion increased significantly (p=0.005), from 51.6±16.0 to 56.4±17.9 mm. However, no significant changes were observed in the TLC, RV diaphragmatic thickness, or diaphragmatic TF (p>0.05). These findings are summarized in Table 3.
Upper extremity flexibility
Upper extremity flexibility outcomes were analyzed using the Wilcoxon signed-rank test. Significant changes were observed in Apley’s test and pectoralis major, pectoralis minor, and upper trapezius flexibility. Right upper trapezius flexibility increased (p<0.05), from 22.0 (20.0–24.8) to 24.0 (22.0–25.5) cm, while left upper trapezius flexibility increased from 23.0 (20.0–25.0) to 23.0 (20.0–26.0) cm (p<0.05). Notably, Apley’s test and pectoralis major and minor flexibility showed significant changes (p<0.001). On the right side, Apley’s test decreased from 19.0 (-2.0 to 28.0) to 13.0 (-4.0 to 25.0) cm, pectoralis major flexibility from 11.8 (8.0–16.0) to 9.0 (6.0–12.0) cm, and pectoralis minor flexibility from 11.5 (10.0–13.0) to 10.0 (8.0–11.5) cm (all p<0.001). On the left side, Apley’s test decreased from 25.0 (15.0–29.0) to 21.0 (11.0–26.0) cm, pectoralis major flexibility from 12.0 (8.6–19.0) to 7.0 (5.0–16.0) cm, and pectoralis minor flexibility from 12.0 (10.0–12.7) to 10.0 (8.0–11.5) cm (all p<0.001). These results are presented in Table 4.
Symptom questionnaire
Symptom questionnaire scores (CAT and mMRC) were compared using the Wilcoxon signed-rank test. In our study, the results of the pretreatment questionnaire revealed that seven participants (36.8%) had a CAT score of less than 10, whereas twelve participants (63.2%) had a CAT score greater than 10. Additionally, fifteen participants (78.9%) had an mMRC score<2 (median 1 [0–1]), while four (21.1%) had scores ≥2. The total CAT score decreased significantly (p<0.05), from 13 (8–20) to 11 (6–17). In contrast, no statistically significant difference was found in the mMRC score (p>0.05). Chest tightness scores decreased (p<0.05), from 2 (0–3) to 1 (0–2). Key findings related to quality of life and symptom relief are shown in Table 5.
In this study, a single session of manual muscle stretching was associated with immediate changes in ERV, diaphragmatic excursion, HRV, respiratory muscle performance, and chest tightness. An increase in ERV is clinically relevant, as impaired expiratory capacity contributes to dynamic hyperinflation in COPD [28]. The observed increase in ERV may reflect changes in chest wall mechanics and respiratory muscle function associated with manual stretching. This change was accompanied by improvements in upper extremity flexibility [18,29]. Our results revealed that the median total CAT score decreased from 13 to 11 (p<0.05). Considering individual CAT items, chest tightness decreased significantly, which may reflect an improvement in perceived breathing comfort following the intervention.
The observed increase in HRV may be associated with changes in autonomic regulation and may relate to improvements in symptom perception. Although RV was not directly measured, future studies incorporating plethysmographic lung volume assessment are warranted to further explore potential changes in dynamic hyperinflation. However, no significant changes were detected in mMRC scores. Since the mMRC assesses dyspnea during physical activity, longer intervention durations and follow-up periods may be needed to elicit meaningful functional improvements.
Autonomic function appeared to change following manual stretching, as reflected by a reduction in resting heart rate and increases in RMSSD and HF components of HRV, which may indicate enhanced parasympathetic modulation; however, they should be interpreted cautiously due to the absence of a control group. Although normalized indices such as LF/HF ratio, high frequency powers of heart rate variability expressed in normal units (HFnu), and low frequency powers of heart rate variability expressed in normal units (LFnu) did not change significantly, this pattern is consistent with previous reports suggesting that absolute HRV parameters may be more sensitive indicators of autonomic changes [30]. Because heightened sympathetic tone is common in COPD patients, such autonomic shifts may have potential clinical relevance, particularly given that the observed reduction in the CAT score exceeded the minimum clinically important difference (two points) [31]. Taken together, both mechanical and autonomic factors may be associated with the observed reduction in chest tightness. These findings suggest that manual muscle stretching may represent a distinct adjunctive approach and warrants further investigation.
Although MIP and MEP percentage-predicted values did not reach statistical significance, the observed increases suggest a trend toward improved respiratory muscle performance. Percentage-predicted values may introduce variability due to reference equations. Clinically, an MIP below 45.1 cmH2O, approximately 66% of the predicted value, has been associated with reduced exercise endurance, highlighting the importance of maintaining inspiratory muscle strength in COPD management [32] The greater relative changes in MIP and MEP compared with spirometric parameters may indicate that manual muscle stretching is more closely associated with respiratory muscle function than airway mechanics. The observed changes could be related to alterations in the length–tension relationship, which may influence muscle contractile performance. Previous studies have reported associations between chest wall movement and respiratory muscle strength [33]. A potential learning effect should also be considered, as the MIP and MEP tests were performed immediately before and after the stretching intervention. Since these measurements are volitional and effort-dependent, increased familiarity with the maneuver during repeated trials may have partially contributed to the observed improvements. This interpretation is consistent with the moderate positive skewness observed in the distributions of MIP and MEP. Although participants received standardized instructions, future studies should incorporate dedicated familiarization sessions to better distinguish true physiological responses from effort-related performance gains.
No significant changes were observed in FEV1 or FVC, which may reflect the limited influence of manual stretching on airway mechanics compared with respiratory muscle function [34]. Similarly, the diaphragmatic TF may require multiple sessions of training rather than a single intervention [35]. These results help define the scope of immediate effects achievable from muscle stretching.
Diaphragmatic excursion is an important clinical marker in COPD [20,36]. In our study, manual muscle stretching increased diaphragmatic excursion from 51.6±16.0 to 56.4±17.9 mm, which is consistent with the findings of previous studies. The increase in diaphragmatic mobility may be related to neuromuscular responses such as reciprocal inhibition, which has been proposed as a possible mechanism contributing to muscle relaxation [36]. Previous research has demonstrated associations between diaphragmatic mobility and exercise capacity [7]. Importantly, lower diaphragmatic mobility was associated with a greater RV (p<0.01, r=-0.62), a major predictor of COPD exacerbations. Therefore, the observed increase in diaphragmatic excursion may have clinical relevance [37]. Although our results did not reveal a significant change in diaphragmatic TF, as noted in previous studies, changes in diaphragmatic TF are typically associated with exercise training rather than stretching interventions.
Given the accessibility of the targeted muscles and their role in compensatory breathing patterns in COPD [38], manual muscle stretching may be feasibly incorporated as a 30-minute adjunctive session in outpatient pulmonary rehabilitation, comprising approximately 15 minutes of passive stretching followed by 15 minutes of a muscle energy technique targeting the upper trapezius, diaphragm, anterior scalene, and pectoral muscles. Further studies are needed to determine the optimal frequency, duration, and long-term role of this intervention alongside standard pulmonary rehabilitation.
This study has several limitations. Potential sources of bias, including measurement variability and learning effects, should be considered. First, the absence of a control group limits causal inference, and the observed changes may be influenced by non-specific effects such as measurement variability or learning effects. Second, the spirometry values reported in Table 2 were based on single study-day measurements rather than post-bronchodilator values used for clinical diagnosis. Slight variations in study-day FEV1/FVC ratios may reflect measurement variability. Therefore, GOLD staging for eligibility was based on historical post-bronchodilator spirometry from medical records rather than the single-day measurements obtained during the research visit. Third, the modest sample size limits the generalizability of the findings. Fourth, RV, an important parameter related to hyperinflation, was not assessed. Fifth, only selected accessory respiratory muscles were targeted; additional muscles such as the sternocleidomastoid and abdominal muscles should be considered in future studies. Sixth, all assessments were performed by a single therapist, which may introduce observer bias. Finally, MIP and MEP are effort-dependent measures, and a learning effect cannot be excluded.
In summary, manual muscle stretching may be associated with immediate mechanical and autonomic changes that alleviate chest tightness in patients with COPD. These preliminary findings support the role of manual stretching techniques as an adjunctive therapy within pulmonary rehabilitation and encourage future work to investigate cumulative effects and functional outcomes.

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

FUNDING INFORMATION

This study was supported by the Ministry of Science and Technology (MOST-106-2314-B-006-023) and National Science and Technology Council (NSTC 113-2410-H-024-012-MY2), Taiwan; NCKUH-11404065 from National Cheng Kung University Hospital; however, the funding agency did not participate in the study design, data collection and analysis, report writing, or the decision to submit the report for publication.

AUTHOR CONTRIBUTION

Conceptualization: Yang HL, Kuo CW, Tsai KL. Methodology: Yang HL, Peng JC, Kuo CW, Tsai KL. Formal analysis: Yang HL, Peng JC, Huang YT, Cheng HC. Funding acquisition: Hung CH, Chen CZ, Tsai KL. Project administration: Chen CZ, Wang SY, Kuo CW, Tsai KL. Visualization: Kuo CW, Tsai KL. Writing – original draft: Yang HL, Peng JC, Tsai KL. Writing – review and editing: Yang HL, Kuo CW, Tsai KL. Approval of final manuscript: all authors.

ACKNOWLEDGMENTS

During the preparation of this manuscript, the authors utilized OpenAI’s ChatGPT for assistance with language refinement, including grammatical corrections and enhancing clarity and conciseness. After utilizing this tool, the authors thoroughly reviewed and revised the content as necessary and assume full responsibility for the final content of the publication.

Supplementary materials can be found via https://doi.org/10.5535/arm.260028.

Supplementary Material S1.

STROBE Statement—Checklist of items that should be included in reports of cohort studies
arm-260028-Supplementary-Material-S1.pdf

Supplementary Table S1.

Comparison of p-values from paired t-test and Wilcoxon signed-rank test for respiratory muscle strength outcomes
arm-260028-Supplementary-Table-S1.pdf
Fig. 1.
Study design and outcome measures. This prospective cohort study included patients with moderate to very severe COPD (n=19) who received passive muscle stretching and muscle energy techniques targeting the anterior scalene, upper trapezius, pectoral, and diaphragm muscles. Outcomes were assessed before and immediately after the intervention, including spirometry (FEV1, FVC, FEV1/FVC), static lung volumes (TV, IRV, IC, ERV, VC), heart rate variability (RHR, SDNN, RMSSD, LF, HF, LF/HF ratio, TP), and diaphragm function (mobility, thickness, thickening fraction). Secondary outcomes included respiratory muscle strength, upper extremity flexibility, and symptom relief. COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; TV, tidal volume; IRV, inspiratory reserve volume; IC, inspiratory capacity; ERV, expiratory reserve volume; VC, vital capacity; RHR, resting heart rate; SDNN, standard deviation of NN intervals; RMSSD, root mean square of successive differences; LF, low frequency; HF, high frequency; LF/HF ratio, low-to-high frequency ratio; TP, total power. Created in BioRender. Tsai KL. (2025) https://BioRender.com/l37c060
arm-260028f1.jpg
Fig. 2.
Manual muscle stretching techniques applied in this study. This figure illustrates the manual muscle stretching techniques administered to patients with chronic obstructive pulmonary disease. Passive stretching was applied to the upper trapezius (A) and diaphragm muscles (B), during which each targeted muscle was elongated and held for 15–30 seconds to reduce muscle tension and facilitate thoracic expansion. Muscle energy techniques were used for the anterior scalene (C) and pectoral muscles (D), consisting of a 5–7 second isometric contraction followed by approximately 30 seconds of passive stretching in the opposite direction to improve rib cage mobility and accessory respiratory muscle flexibility.
arm-260028f2.jpg
Fig. 3.
Percentage distribution of chest tightness scores among chronic obstructive pulmonary disease (COPD) patients. This figure shows the percentage distribution of chest tightness scores (0–5) assessed by the COPD Assessment Test among patients with COPD. The proportions of patients for each score were as follows: 0 (no chest tightness), 31.6%; 1 (very mild), 0%; 2 (mild), 21.1%; 3 (moderate), 31.6%; 4 (severe), 10.5%; and 5 (very severe), 5.3%.
arm-260028f3.jpg
Fig. 4.
Comparison of static lung capacities between pretest and posttest. Nineteen participants were included. Data are presented as mean±standard deviation. The paired t-test was used for intra-group comparisons, with statistical significance at p<0.05. Static lung capacities were measured before and after the intervention. Among these parameters, ERV showed a significant increase after the posttest (p<0.05). TV, tidal volume; IRV, inspiratory reserve volume; VC, vital capacity; IC, inspiratory capacity; ERV, expiratory reserve volume. *Statistical significance at p<0.05.
arm-260028f4.jpg
Fig. 5.
Comparison of heart rate variability (HRV) parameters between pretest and posttest in both time and frequency domains. Nineteen participants were included. Data are presented as median with interquartile range (25th–75th percentiles). In the time domain, resting heart rate (RHR), standard deviation of all normal-to-normal NN intervals (SDNN), and root mean square of successive differences (RMSSD) showed a decrease in RHR and an increase in SDNN and RMSSD following the posttest. In the frequency domain, high frequency (HF), low frequency (LF), and total power (TP) all increased after the posttest. The Wilcoxon signed-rank test was applied to all HRV variables. *Statistical significance at p<0.05.
arm-260028f5.jpg
arm-260028f6.jpg
Table 1.
Participants characteristic
Characteristic All participants (n=19)
Sex, male/female 12/7
Age (yr) 64.2±9.5
Height (cm) 160.7±6.7
Weight (kg) 58.5±10.5
Body mass index (kg/m2) 22.6±3.7
GOLD grade
 Stage 2 10 (52.6)
 Stage 3 6 (31.6)
 Stage 4 3 (15.8)
Clinical symptom questionnaire
 CAT<10 7 (36.8)
 CAT≥10 12 (63.2)
 mMRC≥2 4 (21.1)
 mMRC<2 15 (78.9)

Values are presented as number only, mean±standard deviation, or number (%).

GOLD, Global Initiative for Chronic Obstructive Lung Disease; CAT, COPD (chronic obstructive pulmonary disease) Assessment Test; mMRC, modified Medical Research Council.

Table 2.
Comparison of lung function and respiratory muscle strength before and after manual muscle stretching in patients with COPD
Lung function Pretest Posttest p-value
Spirometry
 FEV1 (L) 1.27±0.56 1.26±0.53 0.543
 FVC (L) 2.10±0.84 2.11±0.80 0.734
 FEV1/FVC ratio (%) 59.95±17.90 55.78±18.38 0.260
 FEV1 (% predicted) 53.5±21.7 53.1±20.9 0.719
 FVC (% predicted) 69.6±21.1 70.2±20.0 0.617
 FEV1/FVC ratio (% predicted) 75.5±17.4 74.5±16.3 0.096
Respiratory muscle strength
 MEP (cm H2O) 56.80±34.95 68.65±36.65 <0.001*
 MIP (cm H2O) -66.01±-45.85 -72.79±-48.23 0.04*
 MEP (% predicted) 0.55±0.30 0.67±0.34 0.120
 MIP (% predicted) 0.76±0.47 0.85±0.51 0.434

Values are presented as mean±standard deviation.

Comparison of lung function and respiratory muscle strength data between pretest and posttest in a total of nineteen participants.

The paired t-test was used for intra-group comparisons, with statistical significance at p<0.05.

All participants met GOLD stage II–IV criteria based on historical post-bronchodilator FEV1 (% predicted) values from clinical records. Additionally, MIP and MEP (% predicted) were calculated based on age- and sex-adjusted reference equations proposed by Evans and Whitelaw [26].

COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; MEP, maximal expiratory pressure; MIP, maximal inspiratory pressure; GOLD, Global Initiative for Chronic Obstructive Lung Disease.

*Statistical significance at p<0.05.

Table 3.
Comparison of diaphragmatic function before and after manual muscle stretching
Diaphragmatic function Pretest Posttest p-value
Diaphragmatic excursion (mm) 51.6±16.0 56.4±17.9 0.005*
TLC diaphragmatic thickness (mm) 4.53±1.19 4.55±1.52 0.95
FRC diaphragmatic thickness (mm) 1.95±0.44 2.07±0.64 0.406
Diaphragmatic TF (%) 1.36±0.63 1.25±0.62 0.489

Values are presented as mean±standard deviation.

Comparison of diaphragmatic function data between pretest and posttest in a total of nineteen participants.

The paired t-test was used for intra-group comparisons, with statistical significance at p<0.05.

TLC, total lung capacity; FRC, functional residual capacity; TF, thickening fraction.

*Statistical significance at p<0.05.

Table 4.
Comparison of UE flexibility before and after manual muscle stretching
UE flexibility (cm) Pretest Posttest p-value
Right side
 Pectoralis major 11.8 (8.0 to 16.0) 9.0 (6.0 to 12.0) <0.001*
 Pectoralis minor 11.5 (10.0 to 13.0) 10.0 (8.0 to 11.5) <0.001*
 Upper trapezius 22.0 (20.0 to 24.8) 24.0 (22.0 to 25.5) 0.031*
 Apley’s scratch test 19.0 (-2.0 to 28.0) 13.0 (-4.0 to 25.0) <0.001*
Left side
 Pectoralis major 12.0 (8.6 to 19.0) 7.0 (5.0 to 16.0) <0.001*
 Pectoralis minor 12.0 (10.0 to 12.7) 10.0 (8.0 to 11.5) <0.001*
 Upper trapezius 23.0 (20.0 to 25.0) 23.0 (20.0 to 26.0) 0.004*
 Apley’s scratch test 25.0 (15.0 to 29.0) 21.0 (11.0 to 26.0) <0.001*

Values are presented as median with interquartile range (25th to 75th percentiles).

Comparison of UE flexibility data between pretest and posttest in a total of nineteen participants.

The Wilcoxon signed-rank test was used for intra-group comparisons, with statistical significance set at p<0.05.

UE, upper extremity.

*Statistical significance at p<0.05.

Table 5.
Comparison of symptom questionnaire scores before and after manual muscle stretching
Symptom questionnaire Pretest Posttest p-value
CAT
 Cough 2 (0–3) 1 (0–2) 0.157
 Phlegm 2 (1–3) 2 (1–3) 0.083
 Chest tightness 2 (0–3) 0.001*
 Breathlessness 2 (1–4) 2 (0–3) 0.083
 Limited activities 0 (0–1) 0 (0–1) >0.999
 Confidence leaving home 1 (0–2) 1 (0–2) 0.317
 Sleeplessness 2 (0–3) 2 (0–3) >0.999
 Energy 2 (1–3) 2 (1–3) 0.18
 CAT total score 13 (8–20) 11 (6–17) 0.001*
 mMRC total score 1 (0–1) 1 (0–1) >0.999

A total of nineteen participant symptom questionnaire data were presented as median with interquartile range (25th–75th percentiles).

The Wilcoxon signed-rank test was used for intra-group comparisons, with statistical significance set at p<0.05.

CAT, COPD (chronic obstructive pulmonary disease) Assessment Test; mMRC, modified Medical Research Council dyspnea scores.

*Statistical significance at p<0.05.

  • 1. Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Am J Respir Crit Care Med 2023;207:819-37.
  • 2. Blinderman CD, Homel P, Billings JA, Tennstedt S, Portenoy RK. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage 2009;38:115-23.
  • 3. Barker N, Everard ML. Getting to grips with ‘dysfunctional breathing’. Paediatr Respir Rev 2015;16:53-61.
  • 4. Soffler MI, Hayes MM, Schwartzstein RM. Respiratory sensations in dynamic hyperinflation: physiological and clinical applications. Respir Care 2017;62:1212-23.
  • 5. O'Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinflation in COPD. COPD 2006;3:219-32.
  • 6. De Troyer A. Effect of hyperinflation on the diaphragm. Eur Respir J 1997;10:708-13.
  • 7. Shiraishi M, Higashimoto Y, Sugiya R, Mizusawa H, Takeda Y, Fujita S, et al. Diaphragmatic excursion correlates with exercise capacity and dynamic hyperinflation in COPD patients. ERJ Open Res 2020;6:00589-2020.
  • 8. Kakavas S, Kotsiou OS, Perlikos F, Mermiri M, Mavrovounis G, Gourgoulianis K, et al. Pulmonary function testing in COPD: looking beyond the curtain of FEV1. NPJ Prim Care Respir Med 2021;31:23.
  • 9. Zalewski P, Slomko J, Zawadka-Kunikowska M. Autonomic dysfunction and chronic disease. Br Med Bull 2018;128:61-74.
  • 10. Raju S, Woo H, Fawzy A, Putcha N, Balasubramanian A, Mathai SC, et al. Decreased cardiac autonomic function is associated with higher exacerbation risk and symptom burden in chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis 2023;10:328-34.
  • 11. Alqahtani JS, Aldhahir AM, Alghamdi SM, Al Ghamdi SS, AlDraiwiesh IA, Alsulayyim AS, et al. A systematic review and meta-analysis of heart rate variability in COPD. Front Cardiovasc Med 2023;10:1070327.
  • 12. Yilmaz Yelvar GD, Çirak Y, Demir YP, Dalkilinç M, Bozkurt B. Immediate effect of manual therapy on respiratory functions and inspiratory muscle strength in patients with COPD. Int J Chron Obstruct Pulmon Dis 2016;11:1353-7.
  • 13. Clarke S, Munro PE, Lee AL. The role of manual therapy in patients with COPD. Healthcare (Basel) 2019;7:21.
  • 14. Cruz-Montecinos C, Godoy-Olave D, Contreras-Briceño FA, Gutiérrez P, Torres-Castro R, Miret-Venegas L, et al. The immediate effect of soft tissue manual therapy intervention on lung function in severe chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2017;12:691-6.
  • 15. Simonelli C, Vitacca M, Vignoni M, Ambrosino N, Paneroni M. Effectiveness of manual therapy in COPD: a systematic review of randomised controlled trials. Pulmonology 2019;25:236-47.
  • 16. Rocha HM, Muniz de Souza HC, Viana R, Neves VR, Dornelas de Andrade A. Immediate effects of rib mobilization and diaphragm release techniques on cardiac autonomic control in patients with chronic obstructive pulmonary disease: a pilot study. J Chiropr Med 2020;19:167-74.
  • 17. Wong A, Figueroa A. Effects of acute stretching exercise and training on heart rate variability: a review. J Strength Cond Res 2021;35:1459-66.
  • 18. Rehman A, Ganai J, Aggarwal R, Alghadir AH, Iqbal ZA. Effect of passive stretching of respiratory muscles on chest expansion and 6-minute walk distance in COPD patients. Int J Environ Res Public Health 2020;17:6480.
  • 19. Mezzani A. Cardiopulmonary exercise testing: basics of methodology and measurements. Ann Am Thorac Soc 2017;14:S3-11.
  • 20. Nair A, Alaparthi GK, Krishnan S, Rai S, Anand R, Acharya V, et al. Comparison of diaphragmatic stretch technique and manual diaphragm release technique on diaphragmatic excursion in chronic obstructive pulmonary disease: a randomized crossover trial. Pulm Med 2019;2019:6364376.
  • 21. Chaitow S, Fritz S. Chaitow's muscle energy techniques. 5th ed. Elsevier; 2023. p. 257-310.
  • 22. Bhakta NR, McGowan A, Ramsey KA, Borg B, Kivastik J, Knight SL, et al. European Respiratory Society/American Thoracic Society technical statement: standardisation of the measurement of lung volumes, 2023 update. Eur Respir J 2023;62:2201519.
  • 23. Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med 2019;200:e70-88.
  • 24. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-65.
  • 25. Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front Public Health 2017;5:258.
  • 26. Evans JA, Whitelaw WA. The assessment of maximal respiratory mouth pressures in adults. Respir Care 2009;54:1348-59.
  • 27. Maskey-Warzechowska M, Mierzejewski M, Gorska K, Golowicz R, Jesien L, Krenke R. Effects of osteopathic manual therapy on hyperinflation in patients with chronic obstructive pulmonary disease: a randomized cross-over study. Adv Exp Med Biol 2019;1222:17-25.
  • 28. Balogh Z, Lengyel L, Varga J. Role of chest expansion in pulmonary rehabilitation. Eur Respir J 2013;42:P3733.
  • 29. Lee J, Hwang S, Han S, Han D. Effects of stretching the scalene muscles on slow vital capacity. J Phys Ther Sci 2016;28:1825-8.
  • 30. Heathers JA. Everything Hertz: methodological issues in short-term frequency-domain HRV. Front Physiol 2014;5:177.
  • 31. Shi Y, Au JSK, Thongprasert S, Srinivasan S, Tsai CM, Khoa MT, et al. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER). J Thorac Oncol 2014;9:154-62.
  • 32. Iwakura M, Wakasa M, Okura K, Kawagoshi A, Sugawara K, Takahashi H, et al. Functionally relevant threshold of inspiratory muscle strength in patients with chronic obstructive pulmonary disease. Respir Med 2021;188:106625.
  • 33. Padkao T, Boonla O. Relationships between respiratory muscle strength, chest wall expansion, and functional capacity in healthy nonsmokers. J Exerc Rehabil 2020;16:189-96.
  • 34. Tian R, Qiao Z, Zhou Z, Zhang J, Sa S, Liu K. Effect of active and passive stretching on symptoms in stable COPD: a systematic review and meta-analysis. Research Square [Preprint]. 2023 [cited 2025 Jan 15]. Available from: https://doi.org/10.21203/rs.3.rs-2546456/v1.
  • 35. González-Álvarez FJ, Valenza MC, Torres-Sánchez I, Cabrera-Martos I, Rodríguez-Torres J, Castellote-Caballero Y. Effects of diaphragm stretching on posterior chain muscle kinematics and rib cage and abdominal excursion: a randomized controlled trial. Braz J Phys Ther 2016;20:405-11.
  • 36. Tsimouris D, Arvanitidis M, Moutzouri M, Koumantakis GA, Gioftsos G, Papandreou M, et al. Is manual therapy of the diaphragm effective for people with obstructive lung diseases? A systematic review. Respir Med Res 2023;83:101002.
  • 37. Schulz A, Erbuth A, Boyko M, Vonderbank S, Gürleyen H, Gibis N, et al. Comparison of ultrasound measurements for diaphragmatic mobility, diaphragmatic thickness, and diaphragm thickening fraction with each other and with lung function in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2022;17:2217-27.
  • 38. Muhammed A, Moiz JA, Singla D, Ali MS, Talwar D. Postural abnormalities in phenotypes of chronic obstructive pulmonary disease. Braz J Phys Ther 2020;24:325-32.

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      Download Citation

      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:

      Include:

      Immediate Effects of Manual Muscle Stretching on Respiratory Capacity, Heart Rate Variability, and Diaphragmatic Function in Patients With COPD
      Ann Rehabil Med. 2026;50(4):265-277.   Published online August 31, 2026
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Immediate Effects of Manual Muscle Stretching on Respiratory Capacity, Heart Rate Variability, and Diaphragmatic Function in Patients With COPD
      Ann Rehabil Med. 2026;50(4):265-277.   Published online August 31, 2026
      Close

      Figure

      • 0
      • 1
      • 2
      • 3
      • 4
      • 5
      Immediate Effects of Manual Muscle Stretching on Respiratory Capacity, Heart Rate Variability, and Diaphragmatic Function in Patients With COPD
      Image Image Image Image Image Image
      Fig. 1. Study design and outcome measures. This prospective cohort study included patients with moderate to very severe COPD (n=19) who received passive muscle stretching and muscle energy techniques targeting the anterior scalene, upper trapezius, pectoral, and diaphragm muscles. Outcomes were assessed before and immediately after the intervention, including spirometry (FEV1, FVC, FEV1/FVC), static lung volumes (TV, IRV, IC, ERV, VC), heart rate variability (RHR, SDNN, RMSSD, LF, HF, LF/HF ratio, TP), and diaphragm function (mobility, thickness, thickening fraction). Secondary outcomes included respiratory muscle strength, upper extremity flexibility, and symptom relief. COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; TV, tidal volume; IRV, inspiratory reserve volume; IC, inspiratory capacity; ERV, expiratory reserve volume; VC, vital capacity; RHR, resting heart rate; SDNN, standard deviation of NN intervals; RMSSD, root mean square of successive differences; LF, low frequency; HF, high frequency; LF/HF ratio, low-to-high frequency ratio; TP, total power. Created in BioRender. Tsai KL. (2025) https://BioRender.com/l37c060
      Fig. 2. Manual muscle stretching techniques applied in this study. This figure illustrates the manual muscle stretching techniques administered to patients with chronic obstructive pulmonary disease. Passive stretching was applied to the upper trapezius (A) and diaphragm muscles (B), during which each targeted muscle was elongated and held for 15–30 seconds to reduce muscle tension and facilitate thoracic expansion. Muscle energy techniques were used for the anterior scalene (C) and pectoral muscles (D), consisting of a 5–7 second isometric contraction followed by approximately 30 seconds of passive stretching in the opposite direction to improve rib cage mobility and accessory respiratory muscle flexibility.
      Fig. 3. Percentage distribution of chest tightness scores among chronic obstructive pulmonary disease (COPD) patients. This figure shows the percentage distribution of chest tightness scores (0–5) assessed by the COPD Assessment Test among patients with COPD. The proportions of patients for each score were as follows: 0 (no chest tightness), 31.6%; 1 (very mild), 0%; 2 (mild), 21.1%; 3 (moderate), 31.6%; 4 (severe), 10.5%; and 5 (very severe), 5.3%.
      Fig. 4. Comparison of static lung capacities between pretest and posttest. Nineteen participants were included. Data are presented as mean±standard deviation. The paired t-test was used for intra-group comparisons, with statistical significance at p<0.05. Static lung capacities were measured before and after the intervention. Among these parameters, ERV showed a significant increase after the posttest (p<0.05). TV, tidal volume; IRV, inspiratory reserve volume; VC, vital capacity; IC, inspiratory capacity; ERV, expiratory reserve volume. *Statistical significance at p<0.05.
      Fig. 5. Comparison of heart rate variability (HRV) parameters between pretest and posttest in both time and frequency domains. Nineteen participants were included. Data are presented as median with interquartile range (25th–75th percentiles). In the time domain, resting heart rate (RHR), standard deviation of all normal-to-normal NN intervals (SDNN), and root mean square of successive differences (RMSSD) showed a decrease in RHR and an increase in SDNN and RMSSD following the posttest. In the frequency domain, high frequency (HF), low frequency (LF), and total power (TP) all increased after the posttest. The Wilcoxon signed-rank test was applied to all HRV variables. *Statistical significance at p<0.05.
      Graphical abstract
      Immediate Effects of Manual Muscle Stretching on Respiratory Capacity, Heart Rate Variability, and Diaphragmatic Function in Patients With COPD
      Characteristic All participants (n=19)
      Sex, male/female 12/7
      Age (yr) 64.2±9.5
      Height (cm) 160.7±6.7
      Weight (kg) 58.5±10.5
      Body mass index (kg/m2) 22.6±3.7
      GOLD grade
       Stage 2 10 (52.6)
       Stage 3 6 (31.6)
       Stage 4 3 (15.8)
      Clinical symptom questionnaire
       CAT<10 7 (36.8)
       CAT≥10 12 (63.2)
       mMRC≥2 4 (21.1)
       mMRC<2 15 (78.9)
      Lung function Pretest Posttest p-value
      Spirometry
       FEV1 (L) 1.27±0.56 1.26±0.53 0.543
       FVC (L) 2.10±0.84 2.11±0.80 0.734
       FEV1/FVC ratio (%) 59.95±17.90 55.78±18.38 0.260
       FEV1 (% predicted) 53.5±21.7 53.1±20.9 0.719
       FVC (% predicted) 69.6±21.1 70.2±20.0 0.617
       FEV1/FVC ratio (% predicted) 75.5±17.4 74.5±16.3 0.096
      Respiratory muscle strength
       MEP (cm H2O) 56.80±34.95 68.65±36.65 <0.001*
       MIP (cm H2O) -66.01±-45.85 -72.79±-48.23 0.04*
       MEP (% predicted) 0.55±0.30 0.67±0.34 0.120
       MIP (% predicted) 0.76±0.47 0.85±0.51 0.434
      Diaphragmatic function Pretest Posttest p-value
      Diaphragmatic excursion (mm) 51.6±16.0 56.4±17.9 0.005*
      TLC diaphragmatic thickness (mm) 4.53±1.19 4.55±1.52 0.95
      FRC diaphragmatic thickness (mm) 1.95±0.44 2.07±0.64 0.406
      Diaphragmatic TF (%) 1.36±0.63 1.25±0.62 0.489
      UE flexibility (cm) Pretest Posttest p-value
      Right side
       Pectoralis major 11.8 (8.0 to 16.0) 9.0 (6.0 to 12.0) <0.001*
       Pectoralis minor 11.5 (10.0 to 13.0) 10.0 (8.0 to 11.5) <0.001*
       Upper trapezius 22.0 (20.0 to 24.8) 24.0 (22.0 to 25.5) 0.031*
       Apley’s scratch test 19.0 (-2.0 to 28.0) 13.0 (-4.0 to 25.0) <0.001*
      Left side
       Pectoralis major 12.0 (8.6 to 19.0) 7.0 (5.0 to 16.0) <0.001*
       Pectoralis minor 12.0 (10.0 to 12.7) 10.0 (8.0 to 11.5) <0.001*
       Upper trapezius 23.0 (20.0 to 25.0) 23.0 (20.0 to 26.0) 0.004*
       Apley’s scratch test 25.0 (15.0 to 29.0) 21.0 (11.0 to 26.0) <0.001*
      Symptom questionnaire Pretest Posttest p-value
      CAT
       Cough 2 (0–3) 1 (0–2) 0.157
       Phlegm 2 (1–3) 2 (1–3) 0.083
       Chest tightness 2 (0–3) 0.001*
       Breathlessness 2 (1–4) 2 (0–3) 0.083
       Limited activities 0 (0–1) 0 (0–1) >0.999
       Confidence leaving home 1 (0–2) 1 (0–2) 0.317
       Sleeplessness 2 (0–3) 2 (0–3) >0.999
       Energy 2 (1–3) 2 (1–3) 0.18
       CAT total score 13 (8–20) 11 (6–17) 0.001*
       mMRC total score 1 (0–1) 1 (0–1) >0.999
      Table 1. Participants characteristic

      Values are presented as number only, mean±standard deviation, or number (%).

      GOLD, Global Initiative for Chronic Obstructive Lung Disease; CAT, COPD (chronic obstructive pulmonary disease) Assessment Test; mMRC, modified Medical Research Council.

      Table 2. Comparison of lung function and respiratory muscle strength before and after manual muscle stretching in patients with COPD

      Values are presented as mean±standard deviation.

      Comparison of lung function and respiratory muscle strength data between pretest and posttest in a total of nineteen participants.

      The paired t-test was used for intra-group comparisons, with statistical significance at p<0.05.

      All participants met GOLD stage II–IV criteria based on historical post-bronchodilator FEV1 (% predicted) values from clinical records. Additionally, MIP and MEP (% predicted) were calculated based on age- and sex-adjusted reference equations proposed by Evans and Whitelaw [26].

      COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; MEP, maximal expiratory pressure; MIP, maximal inspiratory pressure; GOLD, Global Initiative for Chronic Obstructive Lung Disease.

      Statistical significance at p<0.05.

      Table 3. Comparison of diaphragmatic function before and after manual muscle stretching

      Values are presented as mean±standard deviation.

      Comparison of diaphragmatic function data between pretest and posttest in a total of nineteen participants.

      The paired t-test was used for intra-group comparisons, with statistical significance at p<0.05.

      TLC, total lung capacity; FRC, functional residual capacity; TF, thickening fraction.

      Statistical significance at p<0.05.

      Table 4. Comparison of UE flexibility before and after manual muscle stretching

      Values are presented as median with interquartile range (25th to 75th percentiles).

      Comparison of UE flexibility data between pretest and posttest in a total of nineteen participants.

      The Wilcoxon signed-rank test was used for intra-group comparisons, with statistical significance set at p<0.05.

      UE, upper extremity.

      Statistical significance at p<0.05.

      Table 5. Comparison of symptom questionnaire scores before and after manual muscle stretching

      A total of nineteen participant symptom questionnaire data were presented as median with interquartile range (25th–75th percentiles).

      The Wilcoxon signed-rank test was used for intra-group comparisons, with statistical significance set at p<0.05.

      CAT, COPD (chronic obstructive pulmonary disease) Assessment Test; mMRC, modified Medical Research Council dyspnea scores.

      Statistical significance at p<0.05.

      TOP